[Skip to Content]
[Skip to Content Landing]
Medical News and Perspectives
February 9, 2005

Officials Halt NSAID Prevention Trials

JAMA. 2005;293(6):664-665. doi:10.1001/jama.293.6.664

Although clinicians and patients were hoping that the recent rofecoxib debacle would be isolated to that drug alone, new clinical trial data now indicate that other nonsteroidal anti-inflammatory drugs (NSAIDs) may, like rofecoxib, raise the risk of heart attack and stroke. As patients and physicians wait for a clear analysis of the available data, they are left wondering about not only the safety of NSAIDs, but also the fate of clinical studies testing the drugs’ effectiveness for preventing other conditions.

First Page Preview View Large
First page PDF preview
First page PDF preview